17 April 2026 in Journal of Clinical Lipidology
Remnant cholesterol (RC) is a known contributor to cardiovascular disease, but its role in gestational diabetes mellitus (GDM) remains insufficiently characterized. To examine the association between first-trimester RC levels and GDM risk, and to quantify the mediating effects of prepregnancy body mass index (BMI) and insulin sensitivity. This prospective cohort study included 877 pregnant women in Southeastern China. RC was calculated from first-trimester fasting lipid profiles. GDM was diagnosed via a 75 g oral glucose tolerance test at 24 to 28 weeks. Binary logistic regression, restricted cubic splines, and serial mediation models were employed for analysis. Among all participants, 160 (18.2%) developed GDM. After full adjustment for confounders, women in the highest quartile of first-trimester RC had a significantly higher risk of GDM (odds ratio = 2.850, 95% CI: 1.679-4.836) compared with those in the lowest quartile. A significant positive dose-response relationship was observed (P for overall < .001). Serial mediation analysis indicated that the association between RC and GDM was partially mediated through the sequential pathway of prepregnancy BMI → Matsuda index, accounting for 13.50% of the total effect. RC also showed modest predictive performance for GDM (area under the curve = 0.673) compared with conventional lipid parameters. Elevated first-trimester RC is independently associated with increased GDM risk. This association is partially mediated by prepregnancy BMI and subsequent insulin resistance. Measuring RC in early pregnancy may improve the identification of women at high risk for GDM.
1 April 2026 in Diabetes, Metabolic Syndrome and Obesity
Background: Macrosomia is a major adverse outcome associated with gestational diabetes mellitus (GDM), primarily driven by insulin resistance (IR). The triglyceride-glucose (TyG) index is a well-established surrogate marker for insulin resistance; however, its predictive value when combined with obesity indicators remains incompletely defined. This study aimed to compare the predictive performance of the TyG index and its derived indices during the second trimester for the risk of macrosomia in GDM. Methods: The TyG index, TyG body mass index (TyG-BMI), TyG waist circumference (TyG-WC), and TyG waist-to-height ratio (TyG-WHtR) were assessed at 24– 28 weeks of gestation. Their associations with macrosomia were analyzed using binary logistic regression and restricted cubic spline (RCS) analysis. The predictive performance of these indices was compared using receiver operating characteristic (ROC) curves, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). The associations between TyG and its derived indices and the risk of delivering a macrosomic infant were further explored across different subgroups. Results: Logistic regression revealed that GDM women in the highest tertile had a 3.458- and 3.718-fold higher risks of delivering macrosomia compared to the lowest tertile for TyG-BMI and TyG-WC, respectively. RCS analysis showed a dose-response relationship (all P for overall < 0.001). Compared with the conventional TyG index, which had an area under the curve (AUC) of 0.596, both TyG-BMI (AUC = 0.682) and TyG-WC (AUC = 0.681) demonstrated significantly better performance (P < 0.01); furthermore, their superiority was confirmed by significant IDI and NRI values (P < 0.01). The association was more pronounced in primiparous women aged < 35 years (P < 0.05). Conclusion: Elevated second-trimester TyG index and its derived indices are associated with an increased risk of macrosomia in GDM women. TyG-BMI and TyG-WC outperformed the conventional TyG index and may serve as valuable supplementary markers for early risk stratification in GDM.